<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82248">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01825148</url>
  </required_header>
  <id_info>
    <org_study_id>RUNMC-EX-BCM-2012</org_study_id>
    <secondary_id>2012-000619-10</secondary_id>
    <nct_id>NCT01825148</nct_id>
  </id_info>
  <brief_title>GLP-1 Receptor Targeting in Diabetic and Healthy Individuals</brief_title>
  <acronym>GLP-1-CPOP</acronym>
  <official_title>Clinical Proof-of-principle of the Determination of the Beta Cell Mass in Vivo by SPECT Imaging With the 111-In-labeled GLP-1 Analogue DTPA(Diethylenetriamine Pentaacetic Acid)-[K40]-Exendin 4</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether there are differences in pancreatic uptake
      of the radiotracer between healthy individuals and patients with type 1 diabetes. If T1D
      patients have a markedly reduced uptake, the compound may be suitable for estimation of
      pancreatic beta cell mass, i.e. the cells in the pancreas that produce insulin.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>pancreatic uptake of radiolabeled Exendin</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>uptake will be given as counts per MBq injected activity as determined by calibrated SPECT/CT scanner with attenuation correction.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Type 1 Diabetes</arm_group_label>
    <description>patients with long standing T1D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteer</arm_group_label>
    <description>healthy volunteers with normal glucose tolerance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>radiolabeled Exendin</intervention_name>
    <arm_group_label>Type 1 Diabetes</arm_group_label>
    <arm_group_label>Healthy volunteer</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Type 1 Diabetes patients and healthy volunteers responding to advertisment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 1 Diabetes

        Exclusion Criteria:

          -  breast feeding

          -  pregnant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Martin Gotthardt, MD, PhD</last_name>
    <phone>+31 24 36</phone>
    <phone_ext>14048</phone_ext>
    <email>m.gotthardt@nucmed.umcn.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wietske van der Weg, MSc</last_name>
    <phone>+31 24 36</phone>
    <phone_ext>14048</phone_ext>
    <email>w.vanderweg@nucmed.umcn.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Gotthardt, MD, PhD</last_name>
      <phone>+31 24 36</phone>
      <phone_ext>14048</phone_ext>
      <email>m.gotthardt@nucmed.umcn.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 2, 2013</lastchanged_date>
  <firstreceived_date>March 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Radboud University</investigator_affiliation>
    <investigator_full_name>Martin Gotthardt</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pentetic Acid</mesh_term>
    <mesh_term>Edetic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
